ArticleBiotechnology journal2025
Metabolic Engineering of Komagataella phaffii and Process Optimization for Biosynthesis of 1,2,4-Butanetriol From Xylose.
Article in Biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recombinant Expression of Chitinase CtChi70 in Komagataella phaffii for Sustainable N, N'-Diacetyl-Chitobiose Production From Shrimp Shells.Biotechnology journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
1,2,4-butanetriol (BTO) is a four-carbon polyol used as a precursor for synthesizing pharmaceuticals, polymers, and energetic plasticizers. The present study demonstrates the microbial production of BTO from xylose by engineered Komagataella phaffii yeast strains for the first time. The pathway was established through the overexpression of the enzymes xylose dehydrogenase (XylB), xylonate dehydratase (XylD), and 2-ketoacid decarboxylase (KDC). Two xylonate dehydratase genes, xylD-CC from Caulobacter crescentus and xylD-HL from Halomonas lutea, were evaluated in the constructions, both enabling BTO production. Furthermore, to improve BTO production, a central composite design analysis (CCD) was employed, identifying the best cultivation conditions to improve yeast performance. Under these optimized conditions, the engineered K. phaffii strain produced 1.3 g/L of BTO, achieving a 147% increase compared to the initial setup. Although further genetic engineering efforts are required to enhance BTO production, this study provides insights into potential improvement targets and highlights K. phaffii as a promising platform for the bio-based synthesis of chemical compounds like BTO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.